XTalks

OCTOBER 27, 2023

With the FDA clearance, VUNO said it intends to boost its sales and marketing efforts towards US medical institutions. According to a 2023 GlobalData report, it is predicted that the global revenue for AI platforms across healthcare will reach $18.8 The integration of AI technology in medical imaging is growing rapidly.

Sales 69

Sales Clinical Research Marketing Production 69

pharmaphorum

JUNE 8, 2021

Instead, the FDA granted Aduhelm a conditional approval, allowing it to be prescribed and used while Biogen conducts a post-marketing, phase 4 confirmatory study – which could take years to complete. If benefit is not verified, we can act to remove the drug from the market. — Brad Loncar (@bradloncar) June 7, 2021. .”

Drugs 98

Drugs Marketing FDA Approval Trials 98

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. So too are the sales figures. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year. Together, these mRNA jabs have an iron grip on the covid vaccine market – in the US, they have consolidated a 90% market share.

Sales 135

Sales Vaccination Vaccine Marketing 135

Pharmaceutical Technology

OCTOBER 26, 2022

The biotherapeutics market is rapidly growing, with 2021 seeing the highest-ever cell and gene therapy approval number. The first FDA-approved gene therapies (Luxturna and Kymriah) entered the market in 2017. Gene and cell therapies are revolutionising the way healthcare is delivered. The future of cell and gene therapies.

Gene Therapy 130

Gene Therapy Gene Marketing Manufacturing 130

Pharmaceutical Technology

JUNE 21, 2023

In the past year, Hemgenix has been granted approval by the US Food and Drug Administration (FDA) and has received conditional marketing authorisation from the European Commission (EC) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). GlobalData is the parent company of Pharmaceutical Technology.

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

Pharmaceutical Technology

SEPTEMBER 26, 2022

The company told GlobalData PharmSource: “The biosimilar facilities in Austria and Slovenia would continue to manufacture biosimilars for Sandoz under a contractual agreement with Novartis. stake in their consumer healthcare joint venture for $13bn. Strong competition limits Sandoz's growth.

Manufacturing 162

Manufacturing Drugs Branding Sales 162

Pharmaceutical Technology

AUGUST 8, 2022

There’s no dearth of interest, however, in applying digital solutions to healthcare. The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData. GlobalData is the parent company of Pharmaceutical Technology.

FDA Approval 305

FDA Approval Medicine Trials Drugs 305

pharmaphorum

SEPTEMBER 16, 2022

The former blockbuster – first approved back in 1998 – is still making solid sales despite losing patent protection, with AZ booking $410 million from the drug last year, but are expected to drop sharply once Beyfortus and vaccines for RSV prevention reach the market. Both vaccines are also being tested in older adults.

Antibody 59

Antibody Vaccination Vaccine Marketing 59

Pharmaceutical Technology

DECEMBER 9, 2022

Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. It is estimated that Brazil’s SUS currently spends around 10% of the country’s GDP on its healthcare, which before the election, was forecast to rise to 12.6%

Marketing 246

Marketing Sales Production Medicine 246

Pharmaceutical Technology

FEBRUARY 28, 2023

On 27 February, HRA Pharma Rare diseases (HRA RD) announced a partnership with Celnova Pharma to cement its place in the South American market and increase access to needed rare disease treatments. According to GlobalData’s drugs database, only 5% of the globally marketed rare disease drugs are accessible in South and Central America.

Marketing 130

Marketing Drugs Production Sales 130

Pharmaceutical Technology

APRIL 24, 2023

Having steadily risen over the last two decades, 2020 saw more approvals for biopharmaceuticals, often termed as biologics, than any other year in the last decade, according to GlobalData analysis. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

MAY 3, 2023

First generics are the first opportunity manufacturers have to market new generic drug products in the US. Gupta cites pregabalin capsules , used to treat epilepsy and nerve pain, as an example, which experienced a 95% price reduction during the first 12 months of generic sales. from 2001 to 2022.”

Generic Drugs 246

Generic Drugs Branding Drugs Production 246

Pharmaceutical Technology

MAY 26, 2023

The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.” Eckel says that pharmacists have been hit by the repercussions of efforts to make healthcare cheaper. “In

Pharmacy 130

Pharmacy Regulation Insulin Drugs 130

Pharmaceutical Technology

JANUARY 16, 2023

While the impact of underlying inflation is gradually expected to become less severe over the year, there are signs indicating that inflation pressure will be more persistent in some markets than previously assumed. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Manufacturing 162

Manufacturing Marketing Production Sales 162

Pharmaceutical Technology

APRIL 4, 2023

Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic partnership that ensures continuous stock of Orphacol® in Spain. Our ambition is to provide better access to medicines and better healthcare to patients around the world.

Medicine 130

Medicine Marketing Production Genetics 130

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. By GlobalData. Evaluate the effects of COVID-19 on the sector.

Doctors 242

Doctors Doctor Drugs Sales 242

Pharmaceutical Technology

JUNE 22, 2023

However, while the intent is to support antimicrobial drug development, experts say smaller companies in that sector could sell the vouchers to companies that might want to extend the life of other marketed drugs. Hence, some experts remain unsure of how the scheme will incentivise the development of new drugs to fight AMR.

Drugs 130

Drugs Development Pharma Companies Marketing 130

Pharmaceutical Technology

MAY 4, 2023

In April 2023, Washington State Senate passed the My Health, My Data Act designed to protect the “independence and dignity of individuals when making healthcare decisions.” This legislation increases protections regarding the collection, sharing, and sale of health data without the consumer’s knowledge.

Compliance 130

Compliance Regulation Research Genetics 130

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

JANUARY 16, 2023

While the impact of underlying inflation is gradually expected to become less severe over the year, there are signs indicating that inflation pressure will be more persistent in some markets than previously assumed. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Manufacturing 130

Manufacturing Production Marketing Sales 130

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246